Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with...

cafead

Administrator
Staff member
  • cafead   Oct 04, 2022 at 10:52: AM
via Ocugen has secured exclusive regional rights to an intranasally delivered COVID-19 vaccine, positioning it to advance an intervention that already has emergency authorization in India toward the market in other parts of the world.

article source